PALTUSOTINE
PALTUSOTINE is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including PALSONIFY. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- PALTUSOTINE
- Brand Names
- PALSONIFY
- Application Number
- NDA219070
- Sponsor
- Crinetics Pharmaceuticals, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- PALTUSOTINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE PALSONIFY is indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. PALSONIFY is a somatostatin receptor agonist indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option ( 1 ).